Return to Emergent BioSolutions

    The Path to Reemergence

    03.11.2022

    Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma Manufacturing on lessons learned from COVID, and the path forward to future pandemic preparedness.

    Read the full article here. 

     

    CITATION

    K. Langhauser, "Emergent BioSolutions: The path to reemergence," Pharma Manufacturing, February 10, 2022.

    Emergent CDMO

    COVID-19 In The News

    Related Stories

    10.01.2020

    Bloomberg: The Way Ahead

    Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health...

    READ MORE

    07.05.2021

    Lyophilized products are on the rise: Here's what you need to know

    There has been a steady increase in demand for lyophilized products in recent years. Due in large part to biologic drug...

    READ MORE

    03.14.2022

    Emergent Announces Additions to Leadership Team

    Emergent is pleased to announce the addition of two senior leaders to its  CDMO and Quality & Compliance organizations.

    READ MORE